TABLE 2.
Distribution of cancer types amongst patients who developed early cancer compared to those who developed late cancer.
| Cancer type (n, %) | Cancer within 12 months (n = 243) | Cancer after 12 months (n = 2,516) | p-value |
|---|---|---|---|
| Post-transplant lymphoproliferative disease | 62 (25.5) | 351 (14) | <0.001 |
| Urinary tract cancer a | 44 (18.1) | 342 (13.6) | 0.05 |
| Melanoma | 29 (11.9) | 266 (10.6) | 0.51 |
| Other GI tract b | 17 (7.0) | 152 (6.0) | 0.35 |
| Genital3 | 15 (6.2) | 262 (10.4) | 0.04 |
| Colorectal | 12 (4.9) | 197 (7.8) | 0.10 |
| Breast | 12 (4.9) | 143 (5.7) | 0.23 |
| Prostate | 9 (3.7) | 172 (6.8) | 0.06 |
| Lung | 8 (3.3) | 182 (7.2) | 0.02 |
| Thyroid | 7 (2.9) | 54 (2.1) | 0.45 |
| Brain | 3 (1.2) | 24 (1.0) | 0.18 |
| Lip | 1 (0.4) | 30 (1.2) | 0.27 |
| Unknown origin | 2 (0.8) | 70 (2.8) | 0.006 |
| Others | 22 (9.1) | 271 (10.8) | 0.68 |
a
Cancers of the kidney, ureters and bladder.
b
Other gastrointestinal tract cancers (including gall bladder, small intestine, bile duct, pancreas, liver, stomach, esophagus).
c
Cervix, ovaries, uterus, penile.